• 2016
  Hamimi C, David A, Versmisse P, Weiss L, Bruel T, Zucman D, Appay V, Moris A, Ungeheuer MN, Lascoux-Combe C, Barré-Sinoussi F, Muller-Trutwin M, Boufassa F, Lambotte O, Pancino G, Sáez-Cirión A, , , Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles., PLoS One 2016 ; 11(8): e0160251.
• 2015
  Weiss L, Chevalier MF, Assoumou L, Paul JL, Alhenc-Gelas M, Didier C, Taibi S, Manea M, Campa P, Girard PM, Costagliola D, , Rosuvastatin is effective to decrease CD8 T-cell activation only in HIV-infected patients with high residual T-cell activation under antiretroviral therapy, J. Acquir. Immune Defic. Syndr. 2015 Nov;.
• 2015
  Assoumou L, Weiss L, Piketty C, Burgard M, Melard A, Girard PM, Rouzioux C, Costagliola D, , A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control, AIDS 2015 Sep;29(15):2003-7.
• 2015
  Visseaux B, Charpentier C, Collin G, Bertine M, Peytavin G, Damond F, Matheron S, Lefebvre E, Brun-Vézinet F, Descamps D, , Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates, PLoS ONE 2015;10(8):e0134904.
• 2015
  Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, , Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial, Lancet Infect Dis 2015 Jul;15(7):785-92.
• 2015
  Deschildre A, Marguet C, Langlois C, Pin I, Rittié JL, Derelle J, Abou Taam R, Fayon M, Brouard J, Dubus JC, Siret D, Weiss L, Pouessel G, Beghin L, Just J, Real-life long-term omalizumab therapy in children with severe allergic asthma, Eur. Respir. J. 2015 Sep;46(3):856-9.
• 2015
  Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP, , , Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR, N. Engl. J. Med. 2015 Jul;373(3):220-31.
• 2015
  Krastinova E, Seng R, Lechenadec J, Panjo H, Essat A, Makhloufi D, Obadia M, Bernard L, Goujard C, Meyer L, , Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?, BMC Infect. Dis. 2015;15:178.
• 2015
  , Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD, Why START? Reflections that led to the conduct of this large long-term strategic HIV trial, HIV Med. 2015 Apr;16 Suppl 1:1-9.
• 2015
  Wilflingseder D, Schroll A, Hackl H, Gallasch R, Frampton D, Lass-Flörl C, Pancino G, Saez-Cirion A, Lambotte O, Weiss L, Kellam P, Trajanoski Z, Geijtenbeek T, Weiss G, Posch W, Immediate T-Helper 17 Polarization Upon Triggering CD11b/c on HIV-Exposed Dendritic Cells, J. Infect. Dis. 2015 Jul;212(1):44-56.
• 2014
  Lafaurie M, De Sousa B, Ponscarme D, Lapidus N, Daudon M, Weiss L, Rioux C, Fourn E, Katlama C, Molina JM, Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study, PLoS ONE 2014;9(11):e112836.
• 2014
  Costagliola D, Lacombe JM, Ghosn J, Delaugerre C, Pialoux G, Cuzin L, Launay O, Ménard A, de Truchis P, Mary-Krause M, Weiss L, Delfraissy JF, CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression, J Int AIDS Soc 2014;17(4 Suppl 3):19481.
• 2014
  Chevalier MF, Didier C, Petitjean G, Karmochkine M, Girard PM, Barré-Sinoussi F, Scott-Algara D, Weiss L, Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells, J. Infect. Dis. 2015 Mar;211(5):769-79.
• 2014
  Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF, Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study, J. Cyst. Fibros. 2015 Jan;14(1):97-103.
• 2014
  Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A, , Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial, Lancet 2014 Nov;384(9958):1942-51.
• 2014
  Weiss L, Chevalier MF, Assoumou L, Didier C, Girard PM, Piketty C, Costagliola D, Rouzioux C, , T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection, AIDS 2014 Jul;28(11):1683-7.
• 2014
  Iordache L, Launay O, Bouchaud O, Jeantils V, Goujard C, Boue F, Cacoub P, Hanslik T, Mahr A, Lambotte O, Fain O, , Autoimmune diseases in HIV-infected patients: 52 cases and literature review, Autoimmun Rev 2014 Aug;13(8):850-7.
• 2013
  Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP, , Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study, PLoS ONE 2013;8(9):e74868.
• 2013
  Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bourée P, Caumes E, Matheron S, Bouchaud O, , Imported amoebic liver abscess in France, PLoS Negl Trop Dis 2013;7(8):e2333.
• 2013
  Pernot S, Terme M, Zaanan A, Tartour E, Weiss L, Taieb J, Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspects, Clin Res Hepatol Gastroenterol 2014 Feb;38(1):18-23.
• 2013
  Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Meyer L, , Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts, PLoS ONE 2013;8(8):e71473.
• 2013
  Frange P, Meyer L, Jung M, Goujard C, Zucman D, Abel S, Hochedez P, Gousset M, Gascuel O, Rouzioux C, Chaix ML, , Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner, PLoS ONE 2013;8(7):e69144.
• 2013
  Chevalier MF, Petitjean G, Dunyach-Rémy C, Didier C, Girard PM, Manea ME, Campa P, Meyer L, Rouzioux C, Lavigne JP, Barré-Sinoussi F, Scott-Algara D, Weiss L, The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation, PLoS Pathog. 2013;9(6):e1003453.
• 2013
  Deschildre A, Marguet C, Salleron J, Pin I, Rittié JL, Derelle J, Taam RA, Fayon M, Brouard J, Dubus JC, Siret D, Weiss L, Pouessel G, Beghin L, Just J, Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey, Eur. Respir. J. 2013 Nov;42(5):1224-33.
• 2013
  Zucman D, De Truchis P, Peytavin G, Descamps D, Duvivier C, Tegna L, Weiss L, Delassus JL, Benalycherif A, Landman R, Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients, Scand. J. Infect. Dis. 2013 May;45(5):407-10.
• 2013
  Piketty C, Cochand-Priollet B, Lanoy E, Si-Mohamed A, Trabelsi S, Tubiana R, Girard PM, Weiss L, Costagliola D, , Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART, AIDS 2013 Jan;27(3):401-6.
• 2012
  de Parades V, Fathallah N, Barret M, Zeitoun JD, Lemarchand N, Molinié V, Weiss L, [Anal intraepithelial neoplasia], Presse Med 2013 Jul-Aug;42(7-8):1091-9.
• 2012
  Chevalier MF, Weiss L, The split personality of regulatory T cells in HIV infection, Blood 2013 Jan;121(1):29-37.
• 2012
  Lévy Y, Thiébaut R, Gougeon ML, Molina JM, Weiss L, Girard PM, Venet A, Morlat P, Poirier B, Lascaux AS, Boucherie C, Sereni D, Rouzioux C, Viard JP, Lane C, Delfraissy JF, Sereti I, Chêne G, , Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV, AIDS 2012 Mar;26(6):711-20.
• 2012
  Petitjean G, Chevalier MF, Tibaoui F, Didier C, Manea ME, Liovat AS, Campa P, Müller-Trutwin M, Girard PM, Meyer L, Barré-Sinoussi F, Scott-Algara D, Weiss L, , Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection., AIDS 2012 Jan; 26(2): 139-48.
• 2012
  Dray-Spira R, Legeai C, Le Den M, Boué F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L, , Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use, AIDS 2012 Jan;26(2):207-15.
• 2012
  Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C, , Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort, Antivir. Ther. (Lond.) 2012;17(1):91-100.
• 2011
  Aitken ML, Bellon G, De Boeck K, Flume PA, Fox HG, Geller DE, Haarman EG, Hebestreit HU, Lapey A, Schou IM, Zuckerman JB, Charlton B, , Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study, Am. J. Respir. Crit. Care Med. 2012 Mar;185(6):645-52.
• 2011
  Guillot-Delost M, Le Gouvello S, Mesel-Lemoine M, Cheraï M, Baillou C, Simon A, Levy Y, Weiss L, Louafi S, Chaput N, Berrehar F, Kerbrat S, Klatzmann D, Lemoine FM, Human CD90 identifies Th17/Tc17 T cell subsets that are depleted in HIV-infected patients, J. Immunol. 2012 Feb;188(3):981-91.
• 2011
  Stoenoiu MS, Aydin S, Tektonidou M, Ravelingien I, le Guern V, Fiehn C, Remy P, Delahousse M, Petera P, Quémeneur T, Vasconcelos C, D'Cruz D, Gilboe IM, Jadoul M, Karras A, Depresseux G, Guillevin L, Cervera R, Cosyns JP, Houssiau FA, , Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial, Nephrol. Dial. Transplant. 2012 May;27(5):1924-30.
• 2011
  Mole B, Gillaizeau F, Carbonnel E, Pierre I, Brazille P, Grataloup C, Mercier S, Duracinsky M, Weiss L, Piketty C, Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study, AIDS Res. Hum. Retroviruses 2012 Mar;28(3):251-8.
• 2011
  Boufassa F, Saez-Cirion A, Lechenadec J, Zucman D, Avettand-Fenoel V, Venet A, Rouzioux C, Delfraissy JF, Lambotte O, Meyer L, , CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory, PLoS ONE 2011;6(4):e18726.
• 2011
  Charpentier C, Jenabian MA, Piketty C, Karmochkine M, Tisserand P, Laureillard D, Bélec L, Si-Mohamed A, Weiss L, Dynamics of enfuvirtide resistance mutations in enfuvirtide-experienced patients remaining in virological failure under salvage therapy, Scand. J. Infect. Dis. 2011 May;43(5):373-9.
• 2010
  Piketty C, Weiss L, Assoumou L, Burgard M, Mélard A, Ragnaud JM, Bentata M, Girard PM, Rouzioux C, Costagliola D, , A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir, J. Med. Virol. 2010 Nov;82(11):1819-28.
• 2010
  Charpentier C, Weiss L, Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy, Infect Drug Resist 2010;3:103-14.
• 2010
  Hinzpeter A, Aissat A, Sondo E, Costa C, Arous N, Gameiro C, Martin N, Tarze A, Weiss L, de Becdelièvre A, Costes B, Goossens M, Galietta LJ, Girodon E, Fanen P, Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier, PLoS Genet. 2010 Oct;6(10).
• 2010
  Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, , Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial, Ann. Rheum. Dis. 2010 Dec;69(12):2083-9.
• 2010
  Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S, , Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT), HIV Med. 2011 Apr;12(4):219-27.
• 2010
  Sermet-Gaudelus I, Munck A, Rota M, Roussey M, Feldmann D, Nguyen-Khoa T, , [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening], Arch Pediatr 2010 Sep;17(9):1349-58.
• 2010
  Calès P, Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Dib N, Zarski JP, Rousselet MC, , Optimization and robustness of blood tests for liver fibrosis and cirrhosis, Clin. Biochem. 2010 Nov;43(16-17):1315-22.
• 2010
  Fontas E, Kousignian I, Pradier C, Poizot-Martin I, Durier C, Weiss L, Levy Y, Costagliola D, , , IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy–results from the ANRS CO4 cohort, J. Antimicrob. Chemother. 2010 Oct;65(10):2215-23.
• 2010
  Weiss L, Piketty C, Assoumou L, Didier C, Caccavelli L, Donkova-Petrini V, Levy Y, Girard PM, Burgard M, Viard JP, Rouzioux C, Costagliola D, , Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy, PLoS ONE 2010;5(7):e11659.
• 2010
  Weiss L, Letimier FA, Carriere M, Maiella S, Donkova-Petrini V, Targat B, Benecke A, Rogge L, Levy Y, In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients, Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(23):10632-7.
• 2010
  Calès P, Halfon P, Batisse D, Carrat F, Perré P, Penaranda G, Guyader D, d'Alteroche L, Fouchard-Hubert I, Michelet C, Veillon P, Lambert J, Weiss L, Salmon D, Cacoub P, Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection, J. Hepatol. 2010 Aug;53(2):238-44.
• 2010
  Charpentier C, Laureillard D, Piketty C, Tisserand P, Batisse D, Karmochkine M, Si-Mohamed A, Weiss L, High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors, AIDS 2010 Mar;24(6):867-73.
• 2009
  Stegmann S, Manea ME, Charpentier C, Damond F, Karmochkine M, Laureillard D, Si-Mohamed A, Weiss L, Piketty C, Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure, J. Clin. Virol. 2010 Jan;47(1):79-81.
• 2009
  Potard V, Weiss L, Lamontagne F, Rouveix E, Beck-Wirth G, Drogoul-Vey MP, Souala MF, Costagliola D, , Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005, J. Acquir. Immune Defic. Syndr. 2009 Nov;52(3):422-6.
• 2009
  De Castro N, Braun J, Charreau I, Pialoux G, Cotte L, Katlama C, Raffi F, Weiss L, Meynard JL, Yazdanpanah Y, Delaugerre C, Madelaine-Chambrin I, Aboulker JP, Molina JM, , Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial, Clin. Infect. Dis. 2009 Oct;49(8):1259-67.
• 2009
  Cardinaud S, Bouziat R, Rohrlich PS, Tourdot S, Weiss L, Langlade-Demoyen P, Burgevin A, Fiorentino S, van Endert P, Lemonnier FA, Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct, AIDS 2009 Sep;23(15):1945-54.
• 2009
  Fransen S, Karmochkine M, Huang W, Weiss L, Petropoulos CJ, Charpentier C, Longitudinal analysis of raltegravir susceptibility and integrase replication capacity of human immunodeficiency virus type 1 during virologic failure, Antimicrob. Agents Chemother. 2009 Oct;53(10):4522-4.
• 2009
  Viard JP, Fagard C, Chaix ML, Rouzioux C, Bouteloup V, Bentata M, de Verdière NC, Pahlavan G, Weiss L, Lévy Y, Chêne G, , Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients, AIDS 2009 Jul;23(11):1383-8.
• 2009
  Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D, Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV, AIDS 2009 Jun;23(9):1163-9.
• 2009
  Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, Lelièvre JD, Boué F, Molina JM, Rouzioux C, Avettand-Fénoêl V, Croughs T, Beq S, Thiébaut R, Chêne G, Morre M, Delfraissy JF, Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment, J. Clin. Invest. 2009 Apr;119(4):997-1007.
• 2009
  Fontas E, Kousignian I, Pradier C, Duvivier C, Poizot-Martin I, Durier C, Jarrousse B, Weiss L, Levy Y, Costagliola D, , Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4, J. Acquir. Immune Defic. Syndr. 2009 Feb;50(2):206-14.
• 2009
  Walmsley SL, Squires K, Weiss L, Easterbrook P, Orani A, Kraft M, Scherer J, Multidrug-experienced HIV-1-infected women demonstrated similar virological and immunological responses to tipranavir/ritonavir compared with men, AIDS 2009 Jan;23(3):429-31.
• 2009
  Bouillon-Pichault M, Jullien V, Piketty C, Viard JP, Morini JP, Chhun S, Krivine A, Salmon D, Dupin N, Weiss L, Lortholary O, Pons G, Launay O, Treluyer JM, A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients, Antivir. Ther. (Lond.) 2009;14(7):923-9.
• 2008
  Kared H, Lelièvre JD, Donkova-Petrini V, Aouba A, Melica G, Balbo M, Weiss L, Lévy Y, HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection, AIDS 2008 Nov;22(18):2451-60.
• 2008
  Charpentier C, Laureillard D, Sodqi M, Si-Mohamed A, Karmochkine M, Bélec L, Weiss L, Piketty C, Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients, J. Clin. Virol. 2008 Oct;43(2):212-5.
• 2008
  Masquelier B, Assoumou KL, Descamps D, Bocket L, Cottalorda J, Ruffault A, Marcelin AG, Morand-Joubert L, Tamalet C, Charpentier C, Peytavin G, Antoun Z, Brun-Vézinet F, Costagliola D, , Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir, J. Antimicrob. Chemother. 2008 Jun;61(6):1362-8.
• 2008
  Le Saux T, Chhun S, Rey E, Launay O, Weiss L, Viard JP, Pons G, Jullien V, Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008 Apr;865(1-2):81-90.
• 2007
  Durier C, Capitant C, Lascaux AS, Goujard C, Oksenhendler E, Poizot-Martin I, Viard JP, Weiss L, Netzer E, Delfraissy JF, Aboulker JP, Lévy Y, Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials), AIDS 2007 Sep;21(14):1887-97.
• 2007
  , Fox Z, Antunes F, Davey R, Gazzard B, Klimas N, Labriola A, Losso M, Neaton JD, Phillips AN, Ruxrungtham K, Staszewski S, Weiss L, Lundgren JD, Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2, HIV Med. 2007 Mar;8(2):112-23.
• 2007
  Si-Mohamed A, Piketty C, Tisserand P, LeGoff J, Weiss L, Charpentier C, Kazatchkine MD, Bélec L, Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene, J. Acquir. Immune Defic. Syndr. 2007 Jan;44(1):1-5.
• 2006
  Duong Van Huyen JP, Batisse D, Heudes D, Belair MF, Piketty C, Gonzalez-Canali G, Weiss L, Kazatchkine MD, Bruneval P, Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients, Mod. Pathol. 2006 Oct;19(10):1277-88.
• 2006
  Serpaggi J, Chaix ML, Batisse D, Dupont C, Vallet-Pichard A, Fontaine H, Viard JP, Piketty C, Rouveix E, Rouzioux C, Weiss L, Pol S, Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy, AIDS 2006 Jan;20(2):233-40.
• 2005
  Grabar S, Weiss L, Costagliola D, HIV infection in older patients in the HAART era, J. Antimicrob. Chemother. 2006 Jan;57(1):4-7.
• 2005
  Foix-L'Hélias L, Weiss L, Mollet-Boudjemline A, Fallik D, Trioche-Eberschweiler P, Labrune P, Recurring acute abdominal pains in an adolescent as the presenting manifestations of hereditary angioneurotic oedema, Acta Paediatr. 2005 Aug;94(8):1158-61.
• 2005
  Grabar S, Le Moing V, Goujard C, Egger M, Leport C, Kazatchkine MD, Weiss L, Costagliola D, Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection, J. Acquir. Immune Defic. Syndr. 2005 Jul;39(3):284-92.
• 2004
  Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Frémeaux-Bacchi V, Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome, J. Am. Soc. Nephrol. 2005 Feb;16(2):555-63.
• 2004
  Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y, Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients, Blood 2004 Nov;104(10):3249-56.
• 2004
  Batisse D, Karmochkine M, Jacquot C, Kazatchkine MD, Weiss L, Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa, Eur J Gastroenterol Hepatol 2004 Jul;16(7):701-3.
• 2004
  Carbonneil C, Donkova-Petrini V, Aouba A, Weiss L, Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha, J. Immunol. 2004 Jun;172(12):7832-40.
• 2004
  Carbonneil C, Saidi H, Donkova-Petrini V, Weiss L, Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells, Int. Immunol. 2004 Jul;16(7):1037-52.
• 2004
  Cardinaud S, Moris A, Février M, Rohrlich PS, Weiss L, Langlade-Demoyen P, Lemonnier FA, Schwartz O, Habel A, Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames, J. Exp. Med. 2004 Apr;199(8):1053-63.
• 2004
  Dragon-Durey MA, Frémeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Herman Fridman W, Weiss L, Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases, J. Am. Soc. Nephrol. 2004 Mar;15(3):787-95.
• 2004
  Sodqi M, Brazille P, Gonzalez-Canali G, Cornet M, Piketty C, Weiss L, Unusual pulmonary Enterocytozoon bieneusi microsporidiosis in an AIDS patient: case report and review, Scand. J. Infect. Dis. 2004;36(3):230-1.
• 2003
  Diagbouga S, Chazallon C, Kazatchkine MD, Van de Perre P, Inwoley A, M'Boup S, David MP, Ténin AT, Soudré R, Aboulker JP, Weiss L, Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study, AIDS 2003 Oct;17(15):2201-8.
• 2003
  Carbonneil C, Aouba A, Burgard M, Cardinaud S, Rouzioux C, Langlade-Demoyen P, Weiss L, Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells, AIDS 2003 Aug;17(12):1731-40.
• 2003
  Fischbach M, Terzic J, Provot E, Weiss L, Bergere V, Menouer S, Soulami K, Intraperitoneal pressure in children: fill-volume related and impacted by body mass index, Perit Dial Int 2003 Jul-Aug;23(4):391-4.
• 2003
  Duong Van Huyen JP, Landau A, Piketty C, Bélair MF, Batisse D, Gonzalez-Canali G, Weiss L, Jian R, Kazatchkine MD, Bruneval P, Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy, Am. J. Clin. Pathol. 2003 Apr;119(4):546-55.
• 2003
  Levy Y, Durier C, Krzysiek R, Rabian C, Capitant C, Lascaux AS, Michon C, Oksenhendler E, Weiss L, Gastaut JA, Goujard C, Rouzioux C, Maral J, Delfraissy JF, Emilie D, Aboulker JP, , Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial, AIDS 2003 Feb;17(3):343-51.
• 2003
  Brazinsky SA, Lapidus RJ, Weiss LA, Ghafouri M, Fagan NM, Witek TJ, , One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease, Clin Drug Investig 2003;23(3):181-91.
• 2002
  Livolsi A, Feldman J, Feingold J, Weiss L, Alembik Y, Sharifah-Anion IM, Fischbach M, Messer J, Bousquet P, First model of spontaneous vagal hyperreactivity and its mode of genetic transmission, Circulation 2002 Oct;106(18):2301-4.
• 2002
  Frémeaux-Bacchi V, Guinnepain MT, Cacoub P, Dragon-Durey MA, Mouthon L, Blouin J, Cherin P, Laurent J, Piette JC, Fridman WH, Weiss L, Kazatchkine MO, Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2, Am. J. Med. 2002 Aug;113(3):194-9.
• 2002
  Weiss L, [Immune-based therapies and HIV infection], Ann Med Interne (Paris) 2002 Jun;153(4):227-36.
• 2002
  Andréoletti L, Weiss L, Si-Mohamed A, Piketty C, Prazuck T, Calamy G, Malkin JE, Matta M, Mbopi-Kéou FX, Clavel F, Kazatchkine MD, Bélec L, Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene, J. Acquir. Immune Defic. Syndr. 2002 Jan;29(1):102-4.